Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Global - Diabetes Incidence (Million), 2014 & 2035
Figure 3-2: Global - In Vitro Diagnostic Market (Billion US$), 2014-2020
Figure 3-3: Global - In Vitro Diagnostic Market by Region (%), 2014
Figure 3-4: Global - In Vitro Diagnostic Market by Region (%), 2020
Figure 3-5: Global - In Vitro Diagnostic Market by Players (%), 2014
Figure 4-1: Global - Share of POCT in the IVD Market (%), 2014 & 2020
Figure 4-2: Global - Point of Care Testing Market (Billion US$), 2014-2020
Figure 5-1: Global - Point of Care Testing Market by Application (%), 2014
Figure 5-2: Global - Point of Care Testing Market by Application (%), 2020
Figure 5-3: Global - Point of Care Testing Market by Players (%), 2014
Figure 8-1: Global - Point-of-Care Testing Market by Players (%), 2014
Figure 8-2: Roche Holdings Ltd - Revenue by Business Segment (%), 2014
Figure 8-3: Abbott Laboratories - Revenue by Business Segment (%), 2014
Figure 8-4: Abbott Laboratories - Revenue by Region (%), 2014
Figure 8-5: Johnson & Johnson - Revenue by Business Segment (%), 2014
Figure 8-6: Johnson & Johnson - Medical Devices and Dx Revenue by Segment (%), 2014
Figure 8-7: Johnson & Johnson - Revenue by Region (%), 2014
Figure 8-8: Johnson & Johnson - Medical Devices and Dx Revenue by Region (%), 2014
Figure 8-9: Alere Inc. - Revenue by Business Segment (%), 2013
Figure 8-10: Alere Inc. - Professional Diagnostic Division Revenue by Segment (%), 2013
Figure 8-11: Medtronic Inc. - Revenue by Business Segment (%), 2014
Figure 8-12: Medtronic Inc. - Revenue by Region (%), 2014
Figure 8-13: Bayer HealthCare - Revenue by Business Segment (%), 2014
Figure 8-14: Bayer HealthCare - Revenue by Business Region (%), 2014
Figure 8-15: Bayer HealthCare - Consumer Health Revenue by Segment (%), 2014
Figure 8-16: Siemens HealthCare - Revenue by Region (%), 2014
Figure 8-17: Siemens HealthCare - Revenue by Business Segment (%), 2014
Figure 8-18: Bio-Rad - Revenue by Segment (%), 2014
Figure 8-19: Bio-Rad - Revenue by Region (%), 2014
Figure 8-20: Becton Dickinson - Revenue by Business Segment (%), 2014
Figure 8-21: Becton Dickinson - Revenue by Region (%), 2014

List of Tables:

Table 8-1: Roche Holdings Ltd - POCT Product Portfolio
Table 8-2: Roche Holdings Ltd - Key POCT Product Launches for 2015
Table 8-3: Roche Holdings Ltd - Key Financials (Million CHF), 2012-2014
Table 8-4: Roche Holdings Ltd - Strengths and Weaknesses
Table 8-5: Abbott Laboratories - POCT Product Portfolio
Table 8-6: Abbott Laboratories - Key Financials (Million US$), 2012-2014
Table 8-7: Abbott Laboratories - Strengths and Weaknesses
Table 8-8: Johnson & Johnson - POCT Product Portfolio
Table 8-9: Johnson & Johnson - Key Financials (Million US$), 2012-2014
Table 8-10: Johnson & Johnson - Strengths and Weaknesses
Table 8-11: Alere Inc. - POCT Product Portfolio
Table 8-12: Alere Inc. - Key Financials (Million US$), 2011-2013
Table 8-13: Alere Inc. - Strengths and Weaknesses
Table 8-14: Medtronic Inc. - POCT Product Portfolio
Table 8-15: Medtronic Inc. - Key Financials (Million US$), 2012-2014
Table 8-16: Medtronic Inc. - Strengths and Weaknesses
Table 8-17: Bayer HealthCare - POCT Product Portfolio
Table 8-18: Bayer HealthCare - Key Financials (Million €), 2012-2014
Table 8-19: Bayer HealthCare - Strengths and Weaknesses
Table 8-20: Siemens Healthcare - POCT Product Portfolio
Table 8-21: Siemens Healthcare - Key Financials (Million €), 2012-2014
Table 8-22: Siemens Healthcare - Strength and Weaknesses
Table 8-23: Beckman Coulter - POCT Product Portfolio
Table 8-24: Beckman Coulter - Strengths and Weaknesses
Table 8-25: Bio-Rad - POCT Product Portfolio
Table 8-26: Bio-Rad - Key Financials (Million US$) 2012-2014
Table 8-27: Bio-Rad - Strengths and Weaknesses
Table 8-28: Becton Dickinson - POCT Product Portfolio
Table 8-29: Becton Dickinson - Key Financials (Million US$), 2012-2014
Table 8-30: Becton Dickinson - Strengths and Weaknesses